Product
Emtricitabine + Tenofovir Disoproxil
2 clinical trials
5 indications
Indication
Accessibility of Health CareIndication
AdherenceIndication
MedicationIndication
HIVIndication
HIV-1 infectionClinical trial
A Phase II Acceptability Study of Oral Emtricitabine/Tenofovir Alafenamide (F/TAF) vs Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for the Prevention of HIV Acquisition in Adolescent Girls and Young Women (AGYW)Status: Active (not recruiting), Estimated PCD: 2023-12-13
Clinical trial
Efficacy of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults Without Baseline Genotyping Test (D2ARLING Study)Status: Completed, Estimated PCD: 2023-09-30